
Acadia Healthcare (ACHC) Stock Forecast & Price Target
Acadia Healthcare (ACHC) Analyst Ratings
Bulls say
Acadia Healthcare Co Inc. is well-positioned for continued growth due to strong demand in the behavioral health sector, leading to impressive organic expansion through bed additions and new facility developments. The company's net PLGL liability is projected to rise significantly by the end of 2025, reflecting its robust operational capacity and strategic focus on mergers and acquisitions, bolstered by a solid capitalization structure. Furthermore, while faced with some rising costs and claims-related challenges, the guidance indicates an anticipated improvement in organic earnings growth, contributing to a favorable long-term outlook.
Bears say
Acadia Healthcare Co. has revised its guidance for 2025 downwards, reducing EBITDA expectations by approximately 13.4%, primarily due to higher-than-expected litigation expenses that are anticipated to persist into 2026. The company's projected FY26 EBITDA is now expected to be 5% below previous estimates, indicating ongoing challenges with volume softness and elevated operational costs. These factors collectively contribute to a negative outlook on Acadia's financial performance, with forecasted margins decreasing over a multi-year timeframe.
This aggregate rating is based on analysts' research of Acadia Healthcare and is not a guaranteed prediction by Public.com or investment advice.
Acadia Healthcare (ACHC) Analyst Forecast & Price Prediction
Start investing in Acadia Healthcare (ACHC)
Order type
Buy in
Order amount
Est. shares
0 shares